Adverse events75

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 75

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Gastrointestinal disorders - Other, specify	Gastrointestinal disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	13	93	23
other	Abdominal pain	Gastrointestinal disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	22	93	26
other	Infections and infestations - Other, specify	Infections and infestations	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	15	93	18
other	Fever	General disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	12	93	16
other	General disorders and administration site conditions - Other, specify	General disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	9	93	10
other	Diarrhea	Gastrointestinal disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	44	93	100
other	Aspartate aminotransferase increased	Investigations	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	37	93	82
other	Alanine aminotransferase increased	Investigations	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	34	93	81
other	Vomiting	Gastrointestinal disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	21	93	41
other	Constipation	Gastrointestinal disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	13	93	13
other	Urinary tract infection	Infections and infestations	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	6	93	8
other	Fatigue	General disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	67	93	167
other	Investigations - Other, specify	Investigations	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	22	93	94
other	Skin and subcutaneous tissue disorders - Other, specify	Skin and subcutaneous tissue disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	14	93	18
other	Hypomagnesemia	Metabolism and nutrition disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	9	93	11
other	Peripheral sensory neuropathy	Nervous system disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	8	93	15
other	Edema limbs	General disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	6	93	7
other	Hypokalemia	Metabolism and nutrition disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	5	93	5
other	Pain	General disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	5	93	5
serious	Abdominal pain	Gastrointestinal disorders	Advanced and Refractory Endocrine and Neuroendocrine Neoplasms	7	93	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04400474/events

API reference For AI assistants

Adverse events75

Sources 3

Read this list from software.